This dissertation report entitled “The Role and impact of Hospital pharmacy in patient Care and Safety.” is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy (B. Pharm.) Name of the Student:  Md. Rashel Mia - ID.202-0124-225,  Moheiminul Islam Mohim - ID.202-0125-225,  Aneek Chandra Paul - ID.211-0006-225,  Md. Feroz Uddin - ID.211-0011-225,  Md. Mehedi Hassan - ID.211-0012-225,  Jesmin Sultana Jaya - ID.211-0013-225,  Trina Barua - ID.211-0015-225,  Md. Rasel Molla - ID.211-0016-225 Supervised by AsmaKabir Chairman & Assistant Professor, Department of Pharmacy Atish Dipankar University of Science and Technology (ADUST Department of Pharmacy   Atish Dipankar University of Science and Technology (ADUST) Date: 20.11.2025 Abstract Hospital pharmacies play a critical role in enhancing patient care and safety by ensuring the appropriate...

Generic Name Eperisone Hydrochloride Therapeutic Class : Centrally acting Skeletal Muscle Relaxants Indications Improvement of muscular hypertonic symptoms in the following diseases: cervical syndrome, periarthritis of the shoulder, lumbago. Spastic paralysis in the following disease: Cerebrovascular disease, spastic spinal paralysis, cervical spondylosis, postoperative sequelae (including cerebrospinal tumor), sequelae to trauma (spinal trauma, head injury), amyotrophic lateral sclerosis, cerebral palsy, spinocerebellar degeneration, spinal vascular diseases and other encephalomyelopathies. Pharmacology Eperisone is centrally acting skeletal muscle relaxant used to improve myotonic symptoms. Dosage & Administration For adults: Usually 3 tablets per day in three divided doses after each meal. The dosage should be adjusted depending on the patient age and severity of symptoms. Interaction Avoid concomitant use with tolperisone HCl and methocarbamol. Contraindications Eperisone is c...

Generic Name Flupentixol + Melitracen Therapeutic Class: Combined anxiolytics & anti-depressant drugs Indications Flupentixol and Melitracen tablet is indicated in- Anxiety Depression Apathy Psychogenic depression. Depressive neurosses. Masked depression. Psychosomatic affections accompanied by anxiety and apathy. Menopausal depressions. Dysphoria and depression in alcoholics and drug addicts. Pharmacology This consists of two well known and well proven compounds: flupentixol-a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and melitracen-a bipolar thymoleptic with activating properties in low doses. In combination the compounds render a preparation with antidepressant, anxiolytic and activating properties. Maximal serum concentration is reached in about 4 hours after oral administration of flupentixol and in about 4 hours after oral administration of melitracen. The biological half-life of flupentixol is about 35 hours and that of ...

Generic Name Entecavir Therapeutic Class: Hepatic viral infections (Hepatitis B) Indications Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevation in serum aminotransferases (ALT or AST) or histologically active disease. Pharmacology By competing with the natural substrate deoxyguanosine triphosphate, entecavir functionally inhibits all three activities of the HBV polymerase (reverse transcriptase, rt): Base priming, Reverse transcription of the negative strand from the pregenomic messenger RNA, and Synthesis of the positive strand of HBV DNA. Upon activation by kinases, the drug can be incorporated into the DNA which has the ultimate effect of inhibiting the HBV polymerase activity. Dosage & Administration The recommended dose of Entecavir for chronic hepatitis B virus infection in nucleoside-treatment-naive adul...

Signs of frailty may signal future dementia more than a decade before cognitive symptoms appear, new findings that could provide a potential opportunity to identify high-risk populations for targeted enrollment in clinical trials of dementia prevention and treatment. Results from an international study assessing the trajectory of frailty found that levels of frailty increased significantly in the 4-9 years before dementia diagnosis. Even among study participants whose baseline frailty measurements were taken before that accelerated period, frailty was still positively associated with dementia risk, the investigators noted. “We found that with every four to five additional health problems, the risk of developing dementia increased by an average of 40%, whereas the risk was lower for those who were physically fit,” study investigator David Ward, PhD, of the Center for Health Services Research, University of Queensland, Brisbane, Australia, told Medscape Medical News. Photo by David Ward ...